Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients with Relapsed or Refractory Follicular Lymphoma in the United States
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:10822-10824 - Subject
- Language
- ISSN
- 0006-4971